Not a substitute for physical therapy or rehab
mdpi.com A firstinhuman tolerability trial administering IV BPC-157 to healthy volunteers showed good safety profiles at doses up to 0.5 mg/kg, setting the stage for future clinical pharmacokinetic and safety assessments
While Eli Lilly and Company has warning labels about the most common side effects of their GIP/GLP-1 medications, the language on these labels may not have provided adequate warnings about serious GI health risks such as stomach paralysis, intestinal blockages, bowel obstruction, or frequent and excessive vomiting
Our experts will design a customized peptide blend program as part of your hormone optimization plan so you can look, feel, and perform at your peak
Like most medications that affect appetite and digestion, it can cause side effects, especially early on